Odyssean LLC’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Odyssean LLC's AXSM Position: Q3 2026 in Review
Odyssean LLC increased its Axsome Therapeutics (AXSM) stake by 93% in Q3 2026, buying an estimated $2.35M and bringing the position to 22,464 shares worth $4.14M. The position accounts for 0.48% of the portfolio, ranked #92.
Odyssean LLC first reported a position in AXSM in Q4 2025 and has held it in 4 quarters since. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Odyssean LLC held 22,464 shares of Axsome Therapeutics worth $4.14M as of Q3 2026.
- Odyssean LLC bought 10,814 Axsome Therapeutics shares in Q3 2026, an estimated $2.35M.
- Axsome Therapeutics made up 0.48% of Odyssean LLC's portfolio in Q3 2026, its #92 holding.
- Odyssean LLC first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.